Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Doehner, WolframErdmann, Erland
Cairns, Richard
Clark, Andrew L.
Dormandy, John A.
Ferrannini, Ele
Anker, Stefan D.
Affiliation
Charité Medical SchoolIssue Date
2012-12-15
Metadata
Show full item recordAbstract
Although weight reduction is a recommended goal in type 2 diabetes mellitus (T2DM), weight loss is linked to impaired survival in patients with some chronic cardiovascular diseases.Citation
Doehner, W. (2012) 'Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population' Int. J. Cardiol. 162 (1):20-6Publisher
ElsevierPubMed ID
22037349Additional Links
http://www.sciencedirect.com/science/article/pii/S0167527311017682Type
ArticleLanguage
enISSN
1874-1754ae974a485f413a2113503eed53cd6c53
10.1016/j.ijcard.2011.09.039
Scopus Count
Collections
Related articles
- The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study.
- Authors: Erdmann E, Dormandy JA, Charbonnel B, Massi-Benedetti M, Moules IK, Skene AM, PROactive Investigators.
- Issue date: 2007 May 1
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
- Authors: Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Korányi L, Laakso M, Mokán M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J, PROactive Investigators.
- Issue date: 2005 Oct 8
- Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10).
- Authors: Wilcox R, Kupfer S, Erdmann E, PROactive Study investigators.
- Issue date: 2008 Apr
- Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04).
- Authors: Wilcox R, Bousser MG, Betteridge DJ, Schernthaner G, Pirags V, Kupfer S, Dormandy J, PROactive Investigators.
- Issue date: 2007 Mar
- Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial.
- Authors: Mellbin LG, Malmberg K, Waldenström A, Wedel H, Rydén L, DIGAMI 2 investigators.
- Issue date: 2009 May